ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 18 filers reported holding ARCA BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $5,000 | 0.0% | 13,986 | -0.6% | 0.00% | – |
| Q4 2018 | $5,000 | -37.5% | 14,074 | 0.0% | 0.00% | – |
| Q3 2018 | $8,000 | 0.0% | 14,074 | 0.0% | 0.00% | – |
| Q2 2018 | $8,000 | +14.3% | 14,074 | 0.0% | 0.00% | – |
| Q1 2018 | $7,000 | -63.2% | 14,074 | 0.0% | 0.00% | – |
| Q4 2017 | $19,000 | +46.2% | 14,074 | +27.7% | 0.00% | – |
| Q3 2017 | $13,000 | -50.0% | 11,018 | 0.0% | 0.00% | – |
| Q2 2017 | $26,000 | -7.1% | 11,018 | 0.0% | 0.00% | – |
| Q1 2017 | $28,000 | – | 11,018 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aveo Capital Partners, LLC | 93,258 | $47,000 | 0.02% |
| Tekla Capital Management LLC | 811,227 | $405,000 | 0.02% |
| Virtu Financial LLC | 68,000 | $34,000 | 0.00% |
| ROYCE & ASSOCIATES LP | 326,147 | $163,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 776 | $0 | 0.00% |
| NORTHERN TRUST CORP | 14,074 | $7,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11,124 | $6,000 | 0.00% |
| DEUTSCHE BANK AG\ | 352,030 | $175,000 | 0.00% |
| CREDIT SUISSE AG/ | 20,000 | $10,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 88,994 | $44,000 | 0.00% |